<- Go Home
ALZA Corporation
ALZA Corporation, a pharmaceutical research and development company, focuses on the development of drug delivery technologies. It develops transdermal, implant, oral, and liposomal drug delivery technologies that are used in various commercialized pharmaceutical products. The company was founded in 1968 and is based in Vacaville, California. As of June 22, 2001, ALZA Corporation operates as a subsidiary of Johnson & Johnson.
Market Cap
$12.3B
Volume
3.2M
Cash and Equivalents
$692.8M
EBITDA
$346.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$886.2M
Profit Margin
81.67%
52 Week High
$52.98
52 Week Low
$26.20
Dividend
N/A
Price / Book Value
7.44
Price / Earnings
50.49
Price / Tangible Book Value
7.44
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$294.6M
Return on Equity
21.42%
Return on Assets
7.54
Cash and Short Term Investments
$811.5M
Debt
$1.1B
Equity
$1.6B
Revenue
$1.1B
Unlevered FCF
$227.1M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium